In Vitro Diagnostic Solutions (IVDS)

In Vitro Diagnostic Solutions (IVDS) is a biotechnology startup founded in 2015, headquartered in the United States. The company specializes in developing novel testing technologies for the healthcare, veterinary, and consumer markets. With over 25 years of experience in product development and solid phase chemistry, IVDS boasts an impressive track record, including 10 commercial products, 6 U.S. Patents, and co-authorship of 18 SBIR grants. Their expertise lies in formulation chemistry, blood separation, and the semi- and quantitative determination of analytes in biological fluids. IVDS offers a wide range of services and products, including contract development and consulting, portable and affordable point-of-care devices, test strip and meter integration, dry chemistry development, microfluidic design, protein and enzyme stabilization, rapid whole blood separation, novel colorimetric assay development, control solution development and stabilization, SOP writing, FDA Pre-ID guidance, performance protocols, independent testing qualification, and independent stability testing. Despite their strong capabilities, there is no publicly available information about their latest investment or the involved investors.